Differential Sensitivity of Breast Cancer and Melanoma Cells to Proteasome Inhibitor Velcade

International Journal of Molecular Medicine - Greece
doi 10.3892/ijmm_00000090
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Spandidos Publications

Related search

EGFR Inhibitor C225 Increases the Radio-Sensitivity of Human Breast Cancer Cells

Asian Pacific Journal of Cancer Prevention
2019English

Vitamin C Inactivates the Proteasome Inhibitor PS-341 in Human Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2006English

Valproic Acid Restores ERα and Antiestrogen Sensitivity to ERα-negative Breast Cancer Cells

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2010English

Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights Into Differential Inhibitor Sensitivity

Cancer Cell
Cancer ResearchOncologyCell Biology
2007English

P16 Methylation Increases the Sensitivity of Cancer Cells to the CDK4/6 Inhibitor Palbociclib

PLoS ONE
Multidisciplinary
2019English

Curcumin Restores Sensitivity to Retinoic Acid in Triple Negative Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Cellular Morphology-Mediated Proliferation and Drug Sensitivity of Breast Cancer Cells

2017English

P16 Methylation Increases the Sensitivity of Cancer Cells to the CDK4/6 Inhibitor Palbociclib

2019English

Metabolic Imaging Using Hyperpolarized 13 C‐pyruvate to Assess Sensitivity to the B‐Raf Inhibitor Vemurafenib in Melanoma Cells and Xenografts

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy